Inventor · disambiguated record
Dawei Cui
Also filed as: CUI DAWEI
16 granted patents·12 pending applications·83 citations·filing 2010–2024
92Inventor score
Files withAGIOS PHARMACEUTICALS INC16SUZHOU ZELGEN BIOPHARMACEUTICALS CO LTD6SERVIER PHARMACEUTICALS LLC2LEMIEUX RENE M1LUK YAN YEUNG1
Top patents by PatentIndex Score
28 records- 0197US11040036B2Pyruvate kinase activators for use in treating blood disordersAGIOS PHARMACEUTICALS INC·Filed 2020·Granted Jun 22, 2021·7 cites·26 claims
- 0297US9850277B2Therapeutically active compositions and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2016·Granted Dec 26, 2017·22 cites·16 claims
- 0396US9474779B2Therapeutically active compositions and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2013·Granted Oct 25, 2016·36 cites·18 claims
- 0491US11459327B1Cycloalkyl and hetero-cycloalkyl inhibitors, preparation methods therefor, and use thereofSUZHOU ZELGEN BIOPHARMACEUTICALS CO LTD·Filed 2021·Granted Oct 4, 2022·6 cites·6 claims
- 0589US11464775B2Pyruvate kinase modulators and use thereofAGIOS PHARMACEUTICALS INC·Filed 2018·Granted Oct 11, 2022·3 cites·21 claims
- 0689US2025144093A1Pyruvate kinase activators for use in treating blood disordersAGIOS PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0788US11364240B2Pyruvate kinase activators for use in treating blood disordersAGIOS PHARMACEUTICALS INC·Filed 2018·Granted Jun 21, 2022·4 cites·27 claims
- 0887US10717764B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2019·Granted Jul 21, 2020·1 cites·2 claims
- 0985US2024059733A1Therapeutically active compounds and their methods of useSERVIER PHARMACEUTICALS LLC·Filed 2023·Application pending·0 cites
- 1084US12133853B2Pyruvate kinase activators for use in treating blood disordersAGIOS PHARMACEUTICALS INC·Filed 2023·Granted Nov 5, 2024·0 cites·25 claims
- 1183US10640534B2Therapeutically active compositions and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2017·Granted May 5, 2020·2 cites·6 claims
- 1281US11957680B2Pyruvate kinase activators for use in treating blood disordersAGIOS PHARMACEUTICALS INC·Filed 2022·Granted Apr 16, 2024·0 cites·14 claims
- 1379US11872225B2Pyruvate kinase modulators and use thereofAGIOS PHARMACEUTICALS INC·Filed 2022·Granted Jan 16, 2024·0 cites·22 claims
- 1479US11590132B2Pyruvate kinase activators for use in treating blood disordersAGIOS PHARMACEUTICALS INC·Filed 2018·Granted Feb 28, 2023·1 cites·24 claims
- 1574US11667673B2Therapeutically active compounds and their methods of useSERVIER PHARMACEUTICALS LLC·Filed 2020·Granted Jun 6, 2023·0 cites·3 claims
- 1672US11021515B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2020·Granted Jun 1, 2021·0 cites·1 claims
- 1771US10689414B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2018·Granted Jun 23, 2020·0 cites·1 claims
- 1864US2015031627A1Therapeutically active compounds and their methods of useLEMIEUX RENE M·Filed 2014·Application pending·0 cites
- 1963US2023105745A1Cycloalkyl and hetero-cycloalkyl inhibitors, preparation methods therefor, and use thereofSUZHOU ZELGEN BIOPHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 2063US2025206758A1Substituted bridged ring inhibitor, preparation method therefor and application thereofSUZHOU ZELGEN BIOPHARMACEUTICALS CO LTD·Filed 2023·Application pending·0 cites
- 2161US8569463B2Method of covalently modifying proteins with organic molecules to prevent aggregationLUK YAN-YEUNG·Filed 2010·Granted Oct 29, 2013·1 cites·15 claims
- 2260US2017057994A1Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 2359US2016130298A1Therapeutically active compositions and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 2454US2024002362A1Deuterated 2-arylheterocycle-3-oxo-2,3- dihydropyridazine-4-carboxamide inhibitor and preparation method therefor and application thereofSHANGHAI ZELGEN PHARMA TECH CO LTD·Filed 2021·Application pending·0 cites
- 2553US2024336606A1Substituted benzo or pyridopyrimidine amine inhibitor, preparation method therefor, and application thereofSUZHOU ZELGEN BIOPHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 2652US2023118795A1Aryl or heteroaryl pyridone or pyrimidine derivative, preparation method and use thereofSUZHOU ZELGEN BIOPHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 2752US2023008368A1Imidazoquinoline substituted phosphoric ester agonist, and preparation therefor and application thereofSUZHOU ZELGEN BIOPHARMACEUTICALS CO LTD·Filed 2020·Application pending·0 cites
- 2846US2016178633A1Tumor biomarkerUNIV TSINGHUA·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Dawei Cui files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →